Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris
- 1 November 1997
- journal article
- clinical trial
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 37 (5) , 746-754
- https://doi.org/10.1016/s0190-9622(97)70112-9
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: A randomized, placebo-controlled trialObstetrics & Gynecology, 1997
- Hormonal correlates of acne and hirsutismThe American Journal of Medicine, 1995
- A comparison study of lipid and androgen metabolism with triphasic oral contraceptive formulations containing norgestimate or levonorgestrelActa Obstetricia et Gynecologica Scandinavica, 1992
- Cycle control with triphasic norgestimate and ethinyl estradiol, a new oral contraceptive agentActa Obstetricia et Gynecologica Scandinavica, 1992
- Comparative contraceptive efficacy and mechanism of action of the norgestimate‐containing triphasic oral contraceptiveActa Obstetricia et Gynecologica Scandinavica, 1992
- Lipid and carbohydrate effects of a new triphasic oral contraceptive containing norgestimateActa Obstetricia et Gynecologica Scandinavica, 1992
- Current Views on the Aetiology, Pathogenesis and Treatment of Acne VulgarisDrugs, 1990
- Supportive European Data on a New Oral Contraceptive Containing NorgestimateActa Obstetricia et Gynecologica Scandinavica, 1990
- The Selectivity of a New ProgestinActa Obstetricia et Gynecologica Scandinavica, 1990
- Androgen status in women with late onset or persistent acne vulgarisClinical and Experimental Dermatology, 1984